NCT02162745

Brief Summary

Bronchiolitis is a leading cause of acute illness and hospitalization in the first year of life. Most children with bronchiolitis have mild disease and are managed at home with support from primary care providers, while children with more severe symptoms require supportive therapy with oxygen and fluid administration. Neonates may be obligate nasal breathers until they are at least 2 months old and nasal obstruction may play a relevant role in respiratory resistances throughout the first months of life, whereas nasal passages may exhibit as much as 50% of the total airway resistance. Some guidelines recommend to clear the nostrils of secretions to improve airway patency but no controlled trial on the efficacy of nasal irrigation in infants with bronchiolitis was carried out. The aim of this randomized controlled trial is to compare normal saline and hypertonic solution for nasal irrigation versus simple supportive care in infants admitted to Emergency Department with bronchiolitis and mild desaturation.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
133

participants targeted

Target at P25-P50 for phase_3

Timeline
Completed

Started Oct 2012

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2012

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2014

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

June 11, 2014

Completed
2 days until next milestone

First Posted

Study publicly available on registry

June 13, 2014

Completed
Last Updated

June 13, 2014

Status Verified

June 1, 2014

Enrollment Period

1.6 years

First QC Date

June 11, 2014

Last Update Submit

June 12, 2014

Conditions

Keywords

BronchiolitisNormal saline solutionHypertonic solutionNasal irrigation

Outcome Measures

Primary Outcomes (1)

  • Oxygen saturation (%)

    Measurement of arterial oxygen saturation (SpO2) of hemoglobin with digital pulse oximeter

    up to 50 minutes after allocation

Secondary Outcomes (1)

  • Respiratory effort (WARME score)

    5, 15, 20, 50 minutes after allocation

Study Arms (3)

Isotonic solution (NaCl 0.9%)

EXPERIMENTAL

Single nasal irrigation with 1 ml of isotonic solution (NaCl 0.9%) per each nostril

Drug: Isotonic solution (NaCl 0.9%)

Hypertonic solution (NaCl 3%)

EXPERIMENTAL

Single nasal irrigation with 1 ml of hypertonic solution (NaCl 3%) per each nostril

Drug: Hypertonic solution (NaCl 3%)

Supportive care

NO INTERVENTION

Wiping the nose, positioning the child, changing a wet diaper, feeding.

Interventions

Isotonic solution (NaCl 0.9%)
Hypertonic solution (NaCl 3%)

Eligibility Criteria

Age1 Day - 365 Days
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • infants \<1 year
  • diagnosis of bronchiolitis with respiratory distress, rhinitis, cough
  • oxygen saturation between 88 and 94%

You may not qualify if:

  • previous treatments (nasal irrigation or suctioning, oxygen, nebulized drugs, nebulized hypertonic solution, antipyretics up to 6 hours before the study entry, oral steroids at any time before study entry)
  • chronic illness

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Pediatria, Azienda Ospedaliera Santa Maria Degli Angeli

Pordenone, Friuli Venezia Giulia, 33170, Italy

Location

Emergency Department, IRCCS Burlo Garofolo

Trieste, Friuli Venezia Giulia, 34137, Italy

Location

MeSH Terms

Conditions

Bronchiolitis

Interventions

Isotonic SolutionsSodium ChlorideHypertonic Solutions

Condition Hierarchy (Ancestors)

BronchitisRespiratory Tract InfectionsInfectionsBronchial DiseasesRespiratory Tract DiseasesLung Diseases, ObstructiveLung Diseases

Intervention Hierarchy (Ancestors)

SolutionsPharmaceutical PreparationsChloridesHydrochloric AcidChlorine CompoundsInorganic ChemicalsSodium Compounds

Study Officials

  • Dino Barbi, MD

    IRCCS Burlo Garofolo, Trieste, Italy

    STUDY CHAIR
  • Silvana Schreiber, RN

    IRCCS Burlo Garofolo, Trieste, Italy

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD, PhD

Study Record Dates

First Submitted

June 11, 2014

First Posted

June 13, 2014

Study Start

October 1, 2012

Primary Completion

May 1, 2014

Study Completion

May 1, 2014

Last Updated

June 13, 2014

Record last verified: 2014-06

Locations